NFATC3 and neoplasm: In a study [28] involving retroperitoneal liposarcoma, LINC00423 was reported to act as a tumour-repressing lncRNA by downregulating the MAPK pathway (Fig. 1) via destabilizing nuclear factor of activated T cells 3 (NFATC3) (Table 3).